UNITED STATES ARMY MEDICAL RESEARCH
DIRECTORATE-KENYA
☰
USAMRU-K is located in Nairobi, Kenya on the
campus of the Kenya Medical Research Institute
(KEMRI) and is one of five
U.S. DoD overseas research laboratories. The unit
was provisionally established in 1969 at the invitation of the Kenya Government
and was permanently established in 1973.
Over the past 32 years,
research has been conducted on malaria, trypanosomiasis, leishmaniasis,
entomology, HIV/AIDS and arboviruses, with more than 250 manuscripts published
(see publications link). In addition to laboratories housed in Nairobi (where
anti-malarial drug resistance, trypanosome biology, global emerging infectious
diseases (GEIS) are studied), USAMRU-K has other field sites in western Kenya
(Kisumu, Kisian, Kombewa and Kericho) that are mainly concerned with Malaria and
HIV/AIDS.
The USAMRU-K Kisumu Field
Station is based in Kisumu, Kenya located in Nyanza Province along Lake
Victoria. There are five clinic and research departments to include Clinical
Trials, Basic Science, Malaria Diagnostics Center (MDC), Entomology/Vector
Biology Unit, and Malaria Drug Resistance (MDR) Laboratory. The focus of this
program is to develop drugs and vaccines for malaria and other tropical
diseases.
The USAMRU-K Department of Military to Military Activities and
President’s Emergency Plan for AIDS Relief (PEPFAR) program is based in Nairobi.
The focus of this program encompasses HIV/AIDS prevention and treatment,
surveillance for influenza and other diseases that impact force protection and
health readiness in the Kenyan military and research on medical issues of mutual
interest. The USAMRU-K Kericho Field Station is based in Kericho, Kenya. This
program is primarily funded through the Military HIV Research Program and PEPFAR
with the focus of developing drugs and vaccines for HIV prevention and
treatment.
Usamrd-Kenya new
USAMRD-K news
A press release by SightDx about a collaboration with USAMRD-K to test a new
malaria diagnostic device.
TEL AVIV, Israel, October 25, 2016 /PRNewswire/ --
Sight Diagnostics (SightDx) today announced a collaboration with the
United States Army Medical Research Directorate Kenya (USAMRD-K) to
develop and test the next generation of the SightDx malaria diagnostic
technology. Sight Diagnostics will be developing and producing a portable
malaria and complete blood count (CBC) reader that will be calibrated and tested
in clinical trials at the USAMRD-K Field Station in Kisumu, Kenya.